Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

计划入组 200 人 · 首次发布于 2025 年 2 月 27 日

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

计划入组 11 人 · 首次发布于 2018 年 11 月 21 日

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients

计划入组 151 人 · 首次发布于 2015 年 9 月 25 日

cellular kinase inhibitors (GPC)

Mesendo (TCA Cellular Therapy)

Duvac(Cellular Vaccine)(Orgenesis)

CELLULAR SCIENCES INC

United States

Intra-Cellular Therapies

United States

Innovative Cellular Therapeutics Inc

United States

Creative Medical Technology Secures FDA Fast Track Designation for CELZ-201-DDT Back Pain Therapy

36-Month Results of OpRegen Cell Therapy for Geographic Atrophy to Be Presented at CTS 2025

FDA Approves Lifileucel (Amtagvi): First TIL Therapy for Melanoma